1. Home
  2. KTTA vs FOFO Comparison

KTTA vs FOFO Comparison

Compare KTTA & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

SELL

Current Price

$0.48

Market Cap

15.6M

Sector

Health Care

ML Signal

SELL

Logo Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

FOFO

Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

SELL

Current Price

$1.52

Market Cap

15.8M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
KTTA
FOFO
Founded
2020
2017
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.6M
15.8M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
KTTA
FOFO
Price
$0.48
$1.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.4M
10.2K
Earning Date
11-13-2026
12-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 77.07
N/A
EPS
N/A
★ N/A
Revenue
★ $486,559.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$11.09
Revenue Growth
★ 3130.37
N/A
52 Week Low
$0.32
$1.58
52 Week High
$2.06
$14.93

Technical Indicators

Market Signals
Indicator
KTTA
FOFO
Relative Strength Index (RSI) 49.53 30.60
Support Level $0.42 N/A
Resistance Level $0.57 $1.97
Average True Range (ATR) 0.08 0.07
MACD -0.00 -0.01
Stochastic Oscillator 48.59 0.00

Price Performance

Historical Comparison
KTTA
FOFO

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their business and investment objectives. Its business consists of two main business lines: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting and Regulatory compliance and governance consulting, and the asset management services, including fund subscription and fund management services.

Share on Social Networks: